Check back soon for interactive ways of keeping up-to-date with news from the Washington Chapter of the American Parkinson Disease Association!
Teva Announces FDA Approval Received For Azilect® (Rasagiline)
Teva Pharmaceutical Industries Ltd. announced that it has received approval from the U.S. Food and Drug Administration (FDA) for once-daily AZILECT® (rasagiline tablets) as a treatment for Parkinson's disease both as initial monotherapy in early Parkinson's disease patients and as adjunct therapy to levodopa in moderate-to-advanced stages of the disease. Read more.
Executive Director's Report
The Executive Director's Report for Spring 2006 is now available on our site.
APDA Named Safeway's Charity of Choice for March, 2006
Safeway recently named the APDA as its "Charity of Choice" for March of 2006. Collection containers were placed at Safeway checkout stands in the Western region to give Safeway employees and customers a convenient way to help support the APDA with their spare change. Spare change adds up -- this effort raised $47,000! Thank you, Safeway!